-
Signature
-
/s/ Aaron I. Davis, Chief Executive Officer, MVA Investors, LLC
-
Issuer symbol
-
TNGX
-
Transactions as of
-
06 Jun 2024
-
Net transactions value
-
-$985,880
-
Form type
-
4
-
Filing time
-
07 Jun 2024, 21:14:32 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TNGX |
Common Stock |
Sale |
$456,120 |
-63,000 |
-13% |
$7.24 |
420,524 |
06 Jun 2024 |
Direct |
F1 |
| transaction |
TNGX |
Common Stock |
Sale |
$529,760 |
-77,000 |
-18% |
$6.88 |
343,524 |
07 Jun 2024 |
Direct |
F1, F2 |
| holding |
TNGX |
Common Stock |
|
|
|
|
|
5,000 |
06 Jun 2024 |
See footnote |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
The reporting persons may be deemed members of a group that beneficially owns more than 10% of the outstanding shares of common stock, $0.001 par value per share ("Common Stock"), of Tango Therapeutics, Inc. As to any reporting person that is not a beneficial owner of more than 10% of the outstanding shares of Common Stock, this Form 4 shall not be deemed a concession that such person is subject to Section 16 of the Securities Exchange Act of 1934 with respect to the issuer.